These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 9612329)
21. Effect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertension. Mose FH; Jensen JM; Therwani S; Mortensen J; Hansen AB; Bech JN; Pedersen EB Br J Clin Pharmacol; 2015 Sep; 80(3):425-35. PubMed ID: 25778445 [TBL] [Abstract][Full Text] [Related]
22. Role of nitric oxide in the arterial pressure and renal adaptations to long-term changes in sodium intake. Manning RD; Hu L; Reckelhoff JF Am J Physiol; 1997 Apr; 272(4 Pt 2):R1162-9. PubMed ID: 9140016 [TBL] [Abstract][Full Text] [Related]
23. Nitric oxide inhibition in rats improves blood pressure and renal function during hypovolemic shock. Lieberthal W; McGarry AE; Sheils J; Valeri CR Am J Physiol; 1991 Nov; 261(5 Pt 2):F868-72. PubMed ID: 1951718 [TBL] [Abstract][Full Text] [Related]
26. Effect of nitric oxide inhibition on blood pressure and renal sodium handling: a dose-response study in healthy man. Larsen T; Mose FH; Bech JN; Pedersen EB Clin Exp Hypertens; 2012; 34(8):567-74. PubMed ID: 22559218 [TBL] [Abstract][Full Text] [Related]
27. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition. Millar CG; Thiemermann C Br J Pharmacol; 1997 Aug; 121(8):1824-30. PubMed ID: 9283724 [TBL] [Abstract][Full Text] [Related]
28. Nitric oxide: a potential mediator of amino acid-induced renal hyperemia and hyperfiltration. King AJ; Troy JL; Anderson S; Neuringer JR; Gunning M; Brenner BM J Am Soc Nephrol; 1991 Jun; 1(12):1271-7. PubMed ID: 1912389 [TBL] [Abstract][Full Text] [Related]
29. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension. Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753 [TBL] [Abstract][Full Text] [Related]
30. Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature? Schlaich MP; Jacobi J; John S; Delles C; Fleischmann I; Schmieder RE Clin Sci (Lond); 2000 Oct; 99(4):293-302. PubMed ID: 10995594 [TBL] [Abstract][Full Text] [Related]
31. Acute effects of nitric oxide synthase inhibition on systemic, hepatic, and renal hemodynamics in patients with cirrhosis and ascites. Spahr L; Martin PY; Giostra E; Niederberger M; Lang U; Capponi A; Hadengue A J Investig Med; 2002 Mar; 50(2):116-24. PubMed ID: 11928940 [TBL] [Abstract][Full Text] [Related]
32. Effects of atorvastatin on systemic and renal NO dependency in patients with non-diabetic stage II-III chronic kidney disease. Mose FH; Larsen T; Jensen JM; Hansen AB; Bech JN; Pedersen EB Br J Clin Pharmacol; 2014 Oct; 78(4):789-99. PubMed ID: 24697877 [TBL] [Abstract][Full Text] [Related]
33. Effect of L-arginine infusion in normotensive subjects with and without a family history of hypertension. Herlitz H; Jungersten LU; Wikstrand J; Widgren BR Kidney Int; 1999 Nov; 56(5):1838-45. PubMed ID: 10571792 [TBL] [Abstract][Full Text] [Related]
34. Role of nitric oxide in the renal hemodynamic response to a meat meal. Salazar FJ; Alberola A; Nakamura T; Granger JP Am J Physiol; 1994 Oct; 267(4 Pt 2):R1050-5. PubMed ID: 7943415 [TBL] [Abstract][Full Text] [Related]
35. Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: reversal by L-arginine. Wolzt M; Schmetterer L; Ferber W; Artner E; Mensik C; Eichler HG; Krejcy K Am J Physiol; 1997 Feb; 272(2 Pt 2):F178-82. PubMed ID: 9124393 [TBL] [Abstract][Full Text] [Related]
36. Impact of NO-synthase inhibition on renal hemodynamics in normotensive and hypertensive subjects. Jacobi J; Schneider MP; John S; Schmieder RE J Hypertens; 2002 Mar; 20(3):525-30. PubMed ID: 11875321 [TBL] [Abstract][Full Text] [Related]
37. Perfusion pressure and volume status determine the microvascular response of the rat kidney to NG-monomethyl-L-arginine. Lockhart JC; Larson TS; Knox FG Circ Res; 1994 Nov; 75(5):829-35. PubMed ID: 7923628 [TBL] [Abstract][Full Text] [Related]
38. Hyperfiltration and effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus. Cherney DZ; Reich HN; Jiang S; Har R; Nasrallah R; Hébert RL; Lai V; Scholey JW; Sochett EB Am J Physiol Regul Integr Comp Physiol; 2012 Oct; 303(7):R710-8. PubMed ID: 22855276 [TBL] [Abstract][Full Text] [Related]
39. Role of renal interstitial hydrostatic pressure in natriuresis of systemic nitric oxide inhibition. Haas JA; Khraibi AA; Perrella MA; Knox FG Am J Physiol; 1993 Mar; 264(3 Pt 2):F411-4. PubMed ID: 8456954 [TBL] [Abstract][Full Text] [Related]